Pactiv Evergreen Valuation
Is PTVE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PTVE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PTVE ($12.99) is trading below our estimate of fair value ($32.23)
Significantly Below Fair Value: PTVE is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PTVE?
Key metric: As PTVE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is PTVE's PS Ratio? | |
|---|---|
| PS Ratio | 0.4x |
| Sales | US$5.20b |
| Market Cap | US$2.25b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 7.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PTVE's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.1x | ||
SEE Sealed Air | 0.9x | 2.1% | US$5.1b |
SON Sonoco Products | 0.7x | 0.8% | US$4.8b |
PACK Ranpak Holdings | 1.7x | 7.4% | US$570.3m |
GPK Graphic Packaging Holding | 1x | 2.4% | US$8.5b |
PTVE Pactiv Evergreen | 0.4x | 1.2% | US$2.3b |
Price-To-Sales vs Peers: PTVE is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.1x).
Price to Sales Ratio vs Industry
How does PTVE's PS Ratio compare vs other companies in the US Packaging Industry?
| 1 Company | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
OCTO Eightco Holdings | 0.08x | n/a | US$2.74m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: PTVE is good value based on its Price-To-Sales Ratio (0.4x) compared to the US Packaging industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is PTVE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.4x |
| Fair PS Ratio | 0.7x |
Price-To-Sales vs Fair Ratio: PTVE is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$12.99 | US$14.50 +11.6% | 11.8% | US$17.00 | US$12.00 | n/a | 6 |
| Nov ’25 | US$11.31 | US$14.00 +23.8% | 10.1% | US$16.00 | US$12.00 | n/a | 6 |
| Oct ’25 | US$11.55 | US$13.50 +16.9% | 8.2% | US$15.00 | US$12.00 | n/a | 7 |
| Sep ’25 | US$11.80 | US$13.50 +14.4% | 8.2% | US$15.00 | US$12.00 | n/a | 7 |
| Aug ’25 | US$10.46 | US$15.07 +44.1% | 9.5% | US$18.00 | US$13.50 | n/a | 7 |
| Jul ’25 | US$11.40 | US$16.36 +43.5% | 10.4% | US$19.00 | US$13.50 | n/a | 7 |
| Jun ’25 | US$12.36 | US$16.36 +32.3% | 10.4% | US$19.00 | US$13.50 | n/a | 7 |
| May ’25 | US$15.22 | US$16.86 +10.8% | 9.7% | US$19.00 | US$14.00 | n/a | 7 |
| Apr ’25 | US$14.22 | US$16.43 +15.5% | 10.7% | US$19.00 | US$14.00 | n/a | 7 |
| Mar ’25 | US$13.26 | US$16.14 +21.7% | 14.2% | US$19.00 | US$12.00 | n/a | 7 |
| Feb ’25 | US$14.66 | US$15.71 +7.2% | 18.2% | US$19.00 | US$11.00 | n/a | 7 |
| Jan ’25 | US$13.71 | US$12.00 -12.5% | 11.8% | US$14.00 | US$10.00 | n/a | 5 |
| Dec ’24 | US$12.10 | US$11.60 -4.1% | 8.8% | US$13.00 | US$10.00 | n/a | 5 |
| Nov ’24 | US$8.53 | US$9.80 +14.9% | 10.0% | US$11.00 | US$8.00 | US$11.31 | 5 |
| Oct ’24 | US$8.13 | US$10.20 +25.5% | 7.3% | US$11.00 | US$9.00 | US$11.55 | 5 |
| Sep ’24 | US$8.54 | US$10.20 +19.4% | 7.3% | US$11.00 | US$9.00 | US$11.80 | 5 |
| Aug ’24 | US$8.47 | US$9.50 +12.2% | 10.1% | US$11.00 | US$8.00 | US$10.46 | 6 |
| Jul ’24 | US$7.57 | US$9.93 +31.2% | 10.2% | US$11.00 | US$8.00 | US$11.40 | 7 |
| Jun ’24 | US$6.87 | US$9.93 +44.5% | 10.2% | US$11.00 | US$8.00 | US$12.36 | 7 |
| May ’24 | US$7.98 | US$10.64 +33.4% | 16.0% | US$14.00 | US$8.00 | US$15.22 | 7 |
| Apr ’24 | US$8.00 | US$11.93 +49.1% | 11.9% | US$14.00 | US$10.00 | US$14.22 | 7 |
| Mar ’24 | US$11.14 | US$13.00 +16.7% | 11.6% | US$16.00 | US$11.00 | US$13.26 | 7 |
| Feb ’24 | US$11.27 | US$13.00 +15.4% | 11.6% | US$16.00 | US$11.00 | US$14.66 | 7 |
| Jan ’24 | US$11.36 | US$13.25 +16.6% | 11.2% | US$16.00 | US$11.00 | US$13.71 | 8 |
| Dec ’23 | US$11.83 | US$13.25 +12.0% | 11.2% | US$16.00 | US$11.00 | US$12.10 | 8 |
| Nov ’23 | US$10.86 | US$11.94 +9.9% | 17.6% | US$16.00 | US$9.00 | US$8.53 | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Trinseo
US$117.5m
Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.
TSE
US$3.32
7D
-8.3%
1Y
-48.8%
CMOC Group
HK$167.3b
Engages in the mining, beneficiation, smelting, and refining of base and rare metals.
CMCL.F
HK$0.76
7D
0%
1Y
37.8%
Chemtrade Logistics Income Fund
CA$1.4b
Offers industrial chemicals and services in Canada, the United States, and South America.
CGIF.F
CA$8.30
7D
5.2%
1Y
31.5%